ANI Pharmaceuticals, Inc. (BST:BSFA)

Germany flag Germany · Delayed Price · Currency is EUR
69.50
-1.00 (-1.42%)
At close: Dec 4, 2025
31.13%
Market Cap 1.47B
Revenue (ttm) 704.75M
Net Income (ttm) 29.10M
Shares Out n/a
EPS (ttm) 1.43
PE Ratio 50.49
Forward PE 10.30
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 69.50
Previous Close 70.50
Day's Range 69.50 - 69.50
52-Week Range 49.60 - 84.00
Beta n/a
RSI 39.33
Earnings Date Nov 7, 2025

About ANI Pharmaceuticals

ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. It markets, sells, and distributes its products through wholesalers, retail market chains, distributors and specialty pharmacies, group pu... [Read more]

Industry Pharmaceutical Preparations
Founded 2001
Employees 897
Stock Exchange Stuttgart Stock Exchange
Ticker Symbol BSFA
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements

News

There is no news available yet.